Meanwhile, PPAR-γ directly regulates CD36 transcript levels, thus promoting hepatic lipid uptake and affecting lipid metabolism, resulting in hepatic lipid deposition and steatosis in NAFLD (42, 43). Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.